| Product NDC: | 63323-261 | 
| Proprietary Name: | Progesterone | 
| Non Proprietary Name: | PROGESTERONE | 
| Active Ingredient(s): | 50 mg/mL & nbsp; PROGESTERONE | 
| Administration Route(s): | INTRAMUSCULAR | 
| Dosage Form(s): | INJECTION, SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 63323-261 | 
| Labeler Name: | APP Pharmaceuticals, LLC | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA075906 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20010719 | 
| Package NDC: | 63323-261-10 | 
| Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (63323-261-10) > 10 mL in 1 VIAL, MULTI-DOSE | 
| NDC Code | 63323-261-10 | 
| Proprietary Name | Progesterone | 
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (63323-261-10) > 10 mL in 1 VIAL, MULTI-DOSE | 
| Product NDC | 63323-261 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | PROGESTERONE | 
| Dosage Form Name | INJECTION, SOLUTION | 
| Route Name | INTRAMUSCULAR | 
| Start Marketing Date | 20010719 | 
| Marketing Category Name | ANDA | 
| Labeler Name | APP Pharmaceuticals, LLC | 
| Substance Name | PROGESTERONE | 
| Strength Number | 50 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | Progesterone [Chemical/Ingredient],Progesterone [EPC] |